Expression of Pyk2 was significantly reduced in stably transduced U87 and SF767 glioma cells overexpressing miR-23b relative to Pyk2 expression in control transduced U87 and SF767 glioma cells as assayed by immunoblotting (Figure 6B). This evidence concerns the gene PTK2B and central nervous system cancer.